Amgen Officer Files to Sell $300K in Vested Company Shares
AMGEN INC
Subscribe to track AMGN
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
Amgen Officer Files to Sell $300K in Vested Shares
Company: AMGEN INC (AMGN) Form: 144 | Filed: 2025-11-12 Significance: Low
Insider: Khosla Rachna Title: Officer
Transaction: • Type: Proposed Sale • Shares: 890 • Price: ~$337.42 • Value: $300,304
Key Insight: This Form 144 filing indicates a proposed sale of vested compensation shares. The transaction value is negligible (0.00017%) compared to Amgen's $174.28B market capitalization, indicating a routine liquidity event for the insider with no material impact on the company.
This is PUBLIC SEC data for educational purposes. Not investment advice.
Comprehensive Analysis
SEC Filing Analysis: AMGEN INC (AMGN)
Executive Summary
- Trading Significance: Low
- Key Takeaway: An officer at Amgen has filed a notice of proposed sale for approximately $300,000 worth of common stock, a transaction that is immaterial to the company's valuation.
- Market Impact: The sale is too small to have any meaningful impact on the stock price or trading volume.
Company Information
| Field | Value |
|---|---|
| Company | AMGEN INC |
| Ticker Symbol | AMGN |
| CIK | 0000318154 |
| Industry | BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) |
Insider Information
| Field | Value |
|---|---|
| Name | Khosla Rachna |
| CIK | 0001881332 |
| Title/Position | Officer |
| Relationship | Officer |
Transaction Details
| Field | Value |
|---|---|
| Form Type | 144 |
| Transaction Date | 2025-11-12 (Approximate Sale Date) |
| Transaction Code | N/A (Form 144 Proposed Sale) |
| Security Type | Common Stock |
| Shares Involved | 890 |
| Price Per Share | $337.42 (Aggregate) |
| Total Value | $300,303.80 |
| Shares Owned After | Not specified in filing |
| Ownership Type | Not specified in filing |
Financial Impact Assessment
Transaction Materiality
| Metric | Value |
|---|---|
| Transaction Value | $300,303.80 |
| % of Market Cap | 0.00017% |
| Shares Transacted | 890 |
| % of Shares Outstanding | 0.00016% |
| Materiality Assessment | Low |
Impact Evaluation
- Market Cap Context: For a mega-cap company like Amgen with a market capitalization of $174.28 billion, this $300k transaction is financially insignificant.
- Transaction Significance: The sale represents a negligible fraction of both the market capitalization and the total shares outstanding. Such sales are common for executives managing personal finances and are not typically indicative of their outlook on the company's future.
Market Impact Analysis
Stock Impact Prediction
- Direction: Neutral
- Reasoning: The size of the proposed sale is de minimis relative to Amgen's daily trading volume and overall market value. It is highly unlikely to influence investor sentiment or the stock's price.
Volume & Sentiment
- Expected Volume Impact: Negligible. The 890 shares will be easily absorbed by the market without notice.
- Sentiment Indicator: Neutral. This is a routine filing that does not signal any change in the insider's confidence in the company.
Additional Context
Transaction Notes
- This Form 144 is a notice of a proposed sale, not a confirmation of a completed trade.
- The shares being sold were acquired through stock awards as part of the officer's compensation, reinforcing the interpretation of this as a routine liquidity event.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.